|
KMID : 1141720210090010033
|
|
폐쇄성폐질환
2021 Volume.9 No. 1 p.33 ~ p.36
|
|
|
Stable Clinical Course of COPD with LAMA/LABA
|
|
Kang No-Eul
Shin Sun-Hye
Park Hye-Yun
|
|
|
Abstract
|
|
|
|
Dual bronchodilators of two different classes in same device (long-acting beta2-agonist [LABA] and long-acting muscarinic antagonist [LAMA]) is widely used in chronic obstructive pulmonary disease (COPD) treatment, while reserving inhaled corticosteroids (ICS) for the subset of patients with frequent exacerbations. LAMA/LABA dual bronchodilator therapy can provide early improvements in lung function and symptom controls, compared to the mono-bronchodilator therapy in the stable COPD patients. In addition, LAMA/ LABA dual bronchodilator therapy is well-maintained in the stable COPD patients and delays progression to the triple therapy.
|
|
|
KEYWORD
|
|
|
COPD, Bronchodilator, Inhaled corticosteroid
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
|
|